{
  "metadata": {
    "name": "Appendix 3 - CR2 Scenario",
    "description": "Acute treatment of COPD exacerbations with inhaled bronchodilators and oral steroids",
    "authors": [],
    "date_created": "2024-12-10 13:04"
  },
  "parameters": {
    "Country": {
      "hidden": true,
      "value": "AFG",
      "paths": [
        "$.nodes[?(@.id=='lrso81aw')].generate_array.parameters.country",
        "$.nodes[?(@.id=='lrso71jf')].generate_array.parameters.country",
        "$.nodes[?(@.id=='lrso7mga')].generate_array.parameters.country",
        "$.nodes[?(@.id=='DsFreeSus')].generate_array.parameters.country",
        "$.nodes[?(@.id=='Mn5YBbsp')].generate_array.parameters.country",
        "$.links[?(@.id=='3gSm1z84')].generate_array.parameters.country",
        "$.links[?(@.id=='6dXmRQ7e')].generate_array.parameters.country",
        "$.links[?(@.id=='JPGqVn1u')].generate_array.parameters.country",
        "$.links[?(@.id=='k3JrWa6h')].generate_array.parameters.country",
        "$.links[?(@.id=='MfWskKJT')].generate_array.parameters.country",
        "$.links[?(@.id=='eBRm4kvr')].generate_array.parameters.country",
        "$.links[?(@.id=='WALgwDoi')].generate_array.parameters.country",
        "$.links[?(@.id=='HmI3Gkua')].generate_array.parameters.country",
        "$.links[?(@.id=='cz2LeDKw')].generate_array.parameters.country"
      ]
    },
    "Inhaled Salbutamol Baseline Coverage": {
      "value": 0.05,
      "description": "The baseline coverage for the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrso22do')].generate_array.parameters.value"
      ]
    },
    "Inhaled Salbutamol Target Coverage": {
      "value": 0.05,
      "description": "The target coverage for the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsnalk2')].generate_array.parameters.value"
      ]
    },
    "Inhaled Salbutamol Population In Need": {
      "value": 1,
      "description": "The proportion of persons with asthma who require the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsnavq2')].generate_array.parameters.value"
      ]
    },
    "Inhaled Salbutamol Disability Impact": {
      "value": -0.148,
      "description": "The proportion by which the disability weight is reduced due to the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsnjkmt')].generate_array.parameters.value"
      ]
    },
    "Ipratropium Inhaler Baseline Coverage": {
      "value": 0.05,
      "description": "The baseline coverage for the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsnhyyd')].generate_array.parameters.value"
      ]
    },
    "Ipratropium Inhaler Target Coverage": {
      "value": 0.05,
      "description": "The target coverage for the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrso24ss')].generate_array.parameters.value"
      ]
    },
    "Ipratropium Inhaler Population In Need": {
      "value": 0.21,
      "description": "The proportion of persons with asthma who require the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsni0s5')].generate_array.parameters.value"
      ]
    },
    "Ipratropium Inhaler Disability Impact": {
      "value": -0.169,
      "description": "The proportion by which the disability weight is reduced due to the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsnjr1s')].generate_array.parameters.value"
      ]
    },
    "Oral Prednisolone Baseline Coverage": {
      "value": 0.05,
      "description": "The baseline coverage for the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrso28l8')].generate_array.parameters.value"
      ]
    },
    "Oral Prednisolone Target Coverage": {
      "value": 0.95,
      "description": "The target coverage for the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsngpv8')].generate_array.parameters.value"
      ]
    },
    "Oral Prednisolone Population In Need": {
      "value": 0.12,
      "description": "The proportion of persons with asthma who require the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsngte4')].generate_array.parameters.value"
      ]
    },
    "Oral Prednisolone Disability Impact": {
      "value": -0.337,
      "description": "The proportion by which the disability weight is reduced due to the intervention",
      "paths": [
        "$.nodes[?(@.id=='lrsnjnt3')].generate_array.parameters.value"
      ]
    }
  }
}
